Category: Life Sciences
Life Sciences market research reports by Plunkett Research, Ltd.
-
Financial Analysis and Multi-Year Benchmarking: Celldex Therapeutics Inc (CLDX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Celldex Therapeutics Inc (CLDX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forCelldex Therapeutics Inc (CLDX: ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Caribou Biosciences Inc (CRBU:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Caribou Biosciences Inc (CRBU:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forCaribou Biosciences Inc (CRBU:NA ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Charles River Laboratories International Inc (CRL:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Charles River Laboratories International Inc (CRL:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forCharles Rive ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Crinetics Pharmaceuticals Inc (CRNX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Crinetics Pharmaceuticals Inc (CRNX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forCrinetics Pharmaceuticals ... Read More
-
Financial Analysis and Multi-Year Benchmarking: XOMA Corporation (XOMA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: XOMA Corporation (XOMA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forXOMA Corporation (XOMA:NAS) compared to ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Cell Source Inc (CLCS:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Cell Source Inc (CLCS:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forCell Source Inc (CLCS:PINX) compared to ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Eledon Pharmaceuticals Inc (ELDN:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Eledon Pharmaceuticals Inc (ELDN:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forEledon Pharmaceuticals Inc (E ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Microbot Medical Inc (MBOT:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Microbot Medical Inc (MBOT:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forMicrobot Medical Inc (MBOT:NAS) com ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Brainstorm Cell Therapeutics Inc (BCLI:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Brainstorm Cell Therapeutics Inc (BCLI:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forBrainstorm Cell Therape ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Acurx Pharmaceuticals Inc (ACXP:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Acurx Pharmaceuticals Inc (ACXP:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forAcurx Pharmaceuticals Inc (ACX ... Read More
-
Financial Analysis and Multi-Year Benchmarking: American Bio Medica Corporation (ABMC:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: American Bio Medica Corporation (ABMC:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forAmerican Bio Medica Cor ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Adaptive Biotechnologies Corporation (ADPT:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Adaptive Biotechnologies Corporation (ADPT:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forAdaptive Biotechnol ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Kronos Bio Inc (KRON:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Kronos Bio Inc (KRON:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forKronos Bio Inc (KRON:NAS) compared to its ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Harvard Bioscience Inc (HBIO:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Harvard Bioscience Inc (HBIO:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forHarvard Bioscience Inc (HBIO:NAS) ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Arrowhead Pharmaceuticals Inc (ARWR:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Arrowhead Pharmaceuticals Inc (ARWR:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forArrowhead Pharmaceuticals ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Cannibics Pharmaceuticals Inc (CNBX:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Cannibics Pharmaceuticals Inc (CNBX:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forCannibics Pharmaceuticals ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Fate Therapeutics Inc (FATE:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Fate Therapeutics Inc (FATE:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forFate Therapeutics Inc (FATE:NAS) c ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Soligenix Inc (SNGX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Soligenix Inc (SNGX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forSoligenix Inc (SNGX:NAS) compared to its t ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Terns Pharmaceuticals Inc (TERN:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Terns Pharmaceuticals Inc (TERN:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forTerns Pharmaceuticals Inc (TER ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Recursion Pharmaceuticals Inc (RXRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Recursion Pharmaceuticals Inc (RXRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forRecursion Pharmaceuticals ... Read More
-
Financial Analysis and Multi-Year Benchmarking: scPharmaceuticals (SCPH:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: scPharmaceuticals (SCPH:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forscPharmaceuticals (SCPH:NAS) compared ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Puma Biotechnology Inc (PBYI:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Puma Biotechnology Inc (PBYI:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forPuma Biotechnology Inc (PBYI:NAS) ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Ovid Therapeutics (OVID:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Ovid Therapeutics (OVID:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forOvid Therapeutics (OVID:NAS) compared ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Organon and Co (OGN:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Organon and Co (OGN:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forOrganon and Co (OGN:NYS) compared to its t ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Singular Genomics Systems Inc (OMIC:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Singular Genomics Systems Inc (OMIC:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forSingular Genomics Systems ... Read More
Research Assistance
